Paper40599554
Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.
Nimjee SM and 3 others. Cardiol Plus, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair. Papers, record 40599554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40599554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 HL139420 | NHLBI NIH HHS | United States | P01HL139420 | PubMed |
Source NIH RePORTER
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36296562 | Not Just Anticoagulation-New and Old Applications of Heparin. | Molecules | 2022 | https://conductscience.org/library/papers/36296562 | PubMed |
| 2 | 38963354 | Protamine and Heparin Interactions: A Narrative Review. | Ann Card Anaesth | 2024 | https://conductscience.org/library/papers/38963354 | PubMed |
| 3 | 16873382 | Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR). | Br J Anaesth | 2006 | https://conductscience.org/library/papers/16873382 | PubMed |
| 4 | 32417430 | Pathogenesis of heparin-induced thrombocytopenia. | Transl Res | 2020 | https://conductscience.org/library/papers/32417430 | PubMed |
| 5 | 10895825 | Effect of formalin tissue fixation and processing on immunohistochemistry. | Am J Surg Pathol | 2000 | https://conductscience.org/library/papers/10895825 | PubMed |
| 6 | 38985762 | An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38985762 | PubMed |
| 7 | 16765093 | A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery. | Mol Ther | 2006 | https://conductscience.org/library/papers/16765093 | PubMed |
| 8 | 39200826 | Management of Heparin-Induced Thrombocytopenia: A Contemporary Review. | J Clin Med | 2024 | https://conductscience.org/library/papers/39200826 | PubMed |
| 9 | 12214238 | RNA aptamers as reversible antagonists of coagulation factor IXa. | Nature | 2002 | https://conductscience.org/library/papers/12214238 | PubMed |
| 10 | 15660527 | Aptamers: an emerging class of therapeutics. | Annu Rev Med | 2005 | https://conductscience.org/library/papers/15660527 | PubMed |
| 11 | 39725085 | Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia. | J Thromb Haemost | 2025 | https://conductscience.org/library/papers/39725085 | PubMed |
| 12 | 15795162 | The potential of aptamers as anticoagulants. | Trends Cardiovasc Med | 2005 | https://conductscience.org/library/papers/15795162 | PubMed |
| 13 | 15681944 | Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. | Anesthesiology | 2005 | https://conductscience.org/library/papers/15681944 | PubMed |
| 14 | 16308000 | Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery. | J Thorac Cardiovasc Surg | 2005 | https://conductscience.org/library/papers/16308000 | PubMed |
| 15 | 11775016 | Myocardial contraction bands. Definition, quantification and significance in forensic pathology. | Int J Legal Med | 2001 | https://conductscience.org/library/papers/11775016 | PubMed |
| 16 | 8694611 | Direct and interactive effects of cardioplegic arrest and protamine on myocyte contractility. | Ann Thorac Surg | 1996 | https://conductscience.org/library/papers/8694611 | PubMed |
| 17 | 25065530 | Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation. | Chem Biol | 2014 | https://conductscience.org/library/papers/25065530 | PubMed |
| 18 | 28644959 | Generation and characterization of aptamers targeting factor XIa. | Thromb Res | 2017 | https://conductscience.org/library/papers/28644959 | PubMed |
| 19 | 35927191 | Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery. | J Cardiothorac Vasc Anesth | 2022 | https://conductscience.org/library/papers/35927191 | PubMed |
| 20 | 20022942 | An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20022942 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40599554
GET https://conductscience.org/api/papers/v1/40599554/references?page=2